Aligning medications with what matters most for people with dementia using the patient portal
eAlign: A Patient Portal-based Intervention to Align Medications with What Matters Most
This project helps people with Alzheimer's and their caregivers use the medical portal to simplify medicines and focus care on what matters most.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11179290 on NIH RePORTER |
What this research studies
You and your care partner would be helped to sign up for and use the patient portal so care teams can share tailored medication information. The program offers caregiver training on non-drug ways to manage behaviors and schedules pharmacist consultations to talk about stopping or reducing risky medicines. Clinic visits may be audio-recorded so the team can learn how medication choices are made and improve communication. The team aims to reduce unnecessary or harmful medicines for people living with dementia.
Who could benefit from this research
Good fit: Ideal candidates are older adults with Alzheimer's disease or a related dementia who take multiple medications and have a willing care partner who can use the patient portal.
Not a fit: People without dementia, those not taking multiple prescription medications, or those without a care partner or access to the patient portal are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, this could lower side effects, reduce treatment burden, and improve safety by cutting back on unnecessary or risky medications for people with dementia.
How similar studies have performed: Prior deprescribing and caregiver-training efforts have reduced inappropriate medications and some harms, but combining portal-based care-partner engagement with pharmacist-led deprescribing is a newer approach.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Green, Ariel — Johns Hopkins University
- Study coordinator: Green, Ariel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.